Effect  ||| S:0 E:7 ||| NN
of  ||| S:7 E:10 ||| IN
3 ||| S:10 E:11 ||| CD
%  ||| S:11 E:13 ||| NN
hypertonic  ||| S:13 E:24 ||| NN
saline  ||| S:24 E:31 ||| NN
as  ||| S:31 E:34 ||| IN
early  ||| S:34 E:40 ||| JJ
fluid  ||| S:40 E:46 ||| JJ
resuscitation  ||| S:46 E:60 ||| NN
in  ||| S:60 E:63 ||| IN
pediatric  ||| S:63 E:73 ||| JJ
septic  ||| S:73 E:80 ||| JJ
shock  ||| S:80 E:86 ||| NN
The  ||| S:86 E:90 ||| DT
mainstay  ||| S:90 E:99 ||| NN
of  ||| S:99 E:102 ||| IN
therapy  ||| S:102 E:110 ||| NN
in  ||| S:110 E:113 ||| IN
patients  ||| S:113 E:122 ||| NNS
with  ||| S:122 E:127 ||| IN
septic  ||| S:127 E:134 ||| JJ
shock  ||| S:134 E:140 ||| NN
is  ||| S:140 E:143 ||| VBZ
early  ||| S:143 E:149 ||| JJ
and  ||| S:149 E:153 ||| CC
aggressive  ||| S:153 E:164 ||| JJ
intravenous  ||| S:164 E:176 ||| JJ
fluid  ||| S:176 E:182 ||| JJ
resuscitation ||| S:182 E:195 ||| NN
.  ||| S:195 E:197 ||| .
However  ||| S:197 E:205 ||| RB
the  ||| S:205 E:209 ||| DT
type  ||| S:209 E:214 ||| NN
of  ||| S:214 E:217 ||| IN
intravenous  ||| S:217 E:229 ||| JJ
fluid  ||| S:229 E:235 ||| NN
that  ||| S:235 E:240 ||| WDT
would  ||| S:240 E:246 ||| MD
be  ||| S:246 E:249 ||| VB
ideal  ||| S:249 E:255 ||| NN
for  ||| S:255 E:259 ||| IN
managing  ||| S:259 E:268 ||| VBG
septic  ||| S:268 E:275 ||| JJ
shock  ||| S:275 E:281 ||| NN
has  ||| S:281 E:285 ||| VBZ
been  ||| S:285 E:290 ||| VBN
intensely  ||| S:290 E:300 ||| RB
debated ||| S:300 E:307 ||| VBN
.  ||| S:307 E:309 ||| .
In  ||| S:309 E:312 ||| IN
this  ||| S:312 E:317 ||| DT
study ||| S:317 E:322 ||| NN
,  ||| S:322 E:324 ||| ,
the  ||| S:324 E:328 ||| DT
authors  ||| S:328 E:336 ||| NNS
observed  ||| S:336 E:345 ||| VBD
the  ||| S:345 E:349 ||| DT
effects  ||| S:349 E:357 ||| NNS
of  ||| S:357 E:360 ||| IN
3 ||| S:360 E:361 ||| CD
%  ||| S:361 E:363 ||| NN
hypertonic  ||| S:363 E:374 ||| VBZ
saline  ||| S:374 E:381 ||| JJ
solution  ||| S:381 E:390 ||| NN
compared  ||| S:390 E:399 ||| VBN
with  ||| S:399 E:404 ||| IN
normal  ||| S:404 E:411 ||| JJ
saline  ||| S:411 E:418 ||| JJ
solution  ||| S:418 E:427 ||| NN
as  ||| S:427 E:430 ||| IN
early  ||| S:430 E:436 ||| JJ
fluid  ||| S:436 E:442 ||| JJ
resuscitation  ||| S:442 E:456 ||| NN
in  ||| S:456 E:459 ||| IN
children  ||| S:459 E:468 ||| NNS
with  ||| S:468 E:473 ||| IN
septic  ||| S:473 E:480 ||| JJ
shock ||| S:480 E:485 ||| NN
.  ||| S:485 E:487 ||| .
In  ||| S:487 E:490 ||| IN
this  ||| S:490 E:495 ||| DT
prospective  ||| S:495 E:507 ||| JJ
study ||| S:507 E:512 ||| NN
,  ||| S:512 E:514 ||| ,
44  ||| S:514 E:517 ||| CD
septic  ||| S:517 E:524 ||| JJ
shock  ||| S:524 E:530 ||| NN
children  ||| S:530 E:539 ||| NNS
seen  ||| S:539 E:544 ||| VBN
in  ||| S:544 E:547 ||| IN
the  ||| S:547 E:551 ||| DT
intensive  ||| S:551 E:561 ||| JJ
care  ||| S:561 E:566 ||| NN
unit  ||| S:566 E:571 ||| NN
( ||| S:571 E:572 ||| -LRB-
ICU ||| S:572 E:575 ||| NNP
)  ||| S:575 E:577 ||| -RRB-
of  ||| S:577 E:580 ||| IN
the  ||| S:580 E:584 ||| DT
Children ||| S:584 E:592 ||| NNP
's  ||| S:592 E:595 ||| POS
Hospital  ||| S:595 E:604 ||| NNP
Affiliated  ||| S:604 E:615 ||| NNP
to  ||| S:615 E:618 ||| TO
Capital  ||| S:618 E:626 ||| NNP
Institute  ||| S:626 E:636 ||| NNP
of  ||| S:636 E:639 ||| IN
Pediatrics  ||| S:639 E:650 ||| NNP
were  ||| S:650 E:655 ||| VBD
enrolled  ||| S:655 E:664 ||| VBN
from  ||| S:664 E:669 ||| IN
January  ||| S:669 E:677 ||| NNP
2012  ||| S:677 E:682 ||| CD
to  ||| S:682 E:685 ||| TO
January  ||| S:685 E:693 ||| NNP
2014 ||| S:693 E:697 ||| CD
,  ||| S:697 E:699 ||| ,
of  ||| S:699 E:702 ||| IN
whom  ||| S:702 E:707 ||| WP
33  ||| S:707 E:710 ||| CD
were  ||| S:710 E:715 ||| VBD
male  ||| S:715 E:720 ||| JJ
and  ||| S:720 E:724 ||| CC
11  ||| S:724 E:727 ||| CD
were  ||| S:727 E:732 ||| VBD
female ||| S:732 E:738 ||| JJ
.  ||| S:738 E:740 ||| .
Patients  ||| S:740 E:749 ||| NNS
were  ||| S:749 E:754 ||| VBD
randomly  ||| S:754 E:763 ||| RB
divided  ||| S:763 E:771 ||| VBN
into  ||| S:771 E:776 ||| IN
two  ||| S:776 E:780 ||| CD
groups ||| S:780 E:786 ||| NNS
:  ||| S:786 E:788 ||| :
normal  ||| S:788 E:795 ||| JJ
saline  ||| S:795 E:802 ||| JJ
group  ||| S:802 E:808 ||| NN
( ||| S:808 E:809 ||| -LRB-
NS  ||| S:809 E:812 ||| NNP
group ||| S:812 E:817 ||| NN
,  ||| S:817 E:819 ||| ,
24  ||| S:819 E:822 ||| CD
patients ||| S:822 E:830 ||| NNS
)  ||| S:830 E:832 ||| -RRB-
and  ||| S:832 E:836 ||| CC
3 ||| S:836 E:837 ||| CD
%  ||| S:837 E:839 ||| NN
hypertonic  ||| S:839 E:850 ||| VBZ
saline  ||| S:850 E:857 ||| JJ
group  ||| S:857 E:863 ||| NN
( ||| S:863 E:864 ||| -LRB-
HS  ||| S:864 E:867 ||| NNP
group ||| S:867 E:872 ||| NN
, ||| S:872 E:873 ||| ,
20  ||| S:873 E:876 ||| CD
patients ||| S:876 E:884 ||| NNS
) ||| S:884 E:885 ||| -RRB-
.  ||| S:885 E:887 ||| .
There  ||| S:887 E:893 ||| EX
were  ||| S:893 E:898 ||| VBD
no  ||| S:898 E:901 ||| DT
significant  ||| S:901 E:913 ||| JJ
differences  ||| S:913 E:925 ||| NNS
between  ||| S:925 E:933 ||| IN
the  ||| S:933 E:937 ||| DT
2  ||| S:937 E:939 ||| CD
groups  ||| S:939 E:946 ||| NNS
of  ||| S:946 E:949 ||| IN
patients  ||| S:949 E:958 ||| NNS
in  ||| S:958 E:961 ||| IN
age ||| S:961 E:964 ||| NN
,  ||| S:964 E:966 ||| ,
gender ||| S:966 E:972 ||| NN
,  ||| S:972 E:974 ||| ,
pediatric  ||| S:974 E:984 ||| JJ
critical  ||| S:984 E:993 ||| JJ
illness  ||| S:993 E:1001 ||| NN
score  ||| S:1001 E:1007 ||| NN
( ||| S:1007 E:1008 ||| -LRB-
PCIS ||| S:1008 E:1012 ||| NNP
) ||| S:1012 E:1013 ||| -RRB-
,  ||| S:1013 E:1015 ||| ,
oxygenation  ||| S:1015 E:1027 ||| JJ
index  ||| S:1027 E:1033 ||| NN
( ||| S:1033 E:1034 ||| -LRB-
OI  ||| S:1034 E:1037 ||| NNP
=  ||| S:1037 E:1039 ||| SYM
PaO2 ||| S:1039 E:1043 ||| FW
/ ||| S:1043 E:1044 ||| FW
FiO2 ||| S:1044 E:1048 ||| FW
) ||| S:1048 E:1049 ||| -RRB-
,  ||| S:1049 E:1051 ||| ,
arterial  ||| S:1051 E:1060 ||| JJ
lactate ||| S:1060 E:1067 ||| NN
,  ||| S:1067 E:1069 ||| ,
initial  ||| S:1069 E:1077 ||| JJ
hemodynamic  ||| S:1077 E:1089 ||| JJ
parameters ||| S:1089 E:1099 ||| NNS
,  ||| S:1099 E:1101 ||| ,
serum  ||| S:1101 E:1107 ||| JJ
sodium  ||| S:1107 E:1114 ||| NN
and  ||| S:1114 E:1118 ||| CC
treatment  ||| S:1118 E:1128 ||| NN
at  ||| S:1128 E:1131 ||| IN
time  ||| S:1131 E:1136 ||| NN
of  ||| S:1136 E:1139 ||| IN
admission ||| S:1139 E:1148 ||| NN
.  ||| S:1148 E:1150 ||| .
Patients  ||| S:1150 E:1159 ||| NNS
in  ||| S:1159 E:1162 ||| IN
NS  ||| S:1162 E:1165 ||| NNP
group  ||| S:1165 E:1171 ||| NN
received  ||| S:1171 E:1180 ||| VBD
normal  ||| S:1180 E:1187 ||| JJ
saline  ||| S:1187 E:1194 ||| NNS
guided  ||| S:1194 E:1201 ||| VBN
by  ||| S:1201 E:1204 ||| IN
standard  ||| S:1204 E:1213 ||| JJ
therapy ||| S:1213 E:1220 ||| NN
.  ||| S:1220 E:1222 ||| .
Those  ||| S:1222 E:1228 ||| DT
in  ||| S:1228 E:1231 ||| IN
HS  ||| S:1231 E:1234 ||| NNP
group  ||| S:1234 E:1240 ||| NN
received  ||| S:1240 E:1249 ||| VBD
6  ||| S:1249 E:1251 ||| CD
ml ||| S:1251 E:1253 ||| CD
/ ||| S:1253 E:1254 ||| CD
kg  ||| S:1254 E:1257 ||| CD
3 ||| S:1257 E:1258 ||| CD
%  ||| S:1258 E:1260 ||| NN
hypertonic  ||| S:1260 E:1271 ||| NN
saline  ||| S:1271 E:1278 ||| NN
as  ||| S:1278 E:1281 ||| IN
a  ||| S:1281 E:1283 ||| DT
single  ||| S:1283 E:1290 ||| JJ
bolus  ||| S:1290 E:1296 ||| NN
over  ||| S:1296 E:1301 ||| IN
10  ||| S:1301 E:1304 ||| CD
min  ||| S:1304 E:1308 ||| NN
to  ||| S:1308 E:1311 ||| TO
15  ||| S:1311 E:1314 ||| CD
min  ||| S:1314 E:1318 ||| NN
with  ||| S:1318 E:1323 ||| IN
a  ||| S:1323 E:1325 ||| DT
maximum  ||| S:1325 E:1333 ||| NN
of  ||| S:1333 E:1336 ||| IN
2  ||| S:1336 E:1338 ||| CD
boluses  ||| S:1338 E:1346 ||| NNS
and  ||| S:1346 E:1350 ||| CC
other  ||| S:1350 E:1356 ||| JJ
standard  ||| S:1356 E:1365 ||| JJ
therapy ||| S:1365 E:1372 ||| NN
.  ||| S:1372 E:1374 ||| .
Heart  ||| S:1374 E:1380 ||| NN
rate  ||| S:1380 E:1385 ||| NN
( ||| S:1385 E:1386 ||| -LRB-
HR ||| S:1386 E:1388 ||| NNP
) ||| S:1388 E:1389 ||| -RRB-
,  ||| S:1389 E:1391 ||| ,
mean  ||| S:1391 E:1396 ||| VBP
arterial  ||| S:1396 E:1405 ||| JJ
blood  ||| S:1405 E:1411 ||| NN
pressure  ||| S:1411 E:1420 ||| NN
( ||| S:1420 E:1421 ||| -LRB-
MAP ||| S:1421 E:1424 ||| NNP
) ||| S:1424 E:1425 ||| -RRB-
,  ||| S:1425 E:1427 ||| ,
arterial  ||| S:1427 E:1436 ||| JJ
lactate ||| S:1436 E:1443 ||| NN
,  ||| S:1443 E:1445 ||| ,
oxygenation  ||| S:1445 E:1457 ||| JJ
index ||| S:1457 E:1462 ||| NN
,  ||| S:1462 E:1464 ||| ,
urine  ||| S:1464 E:1470 ||| JJ
output ||| S:1470 E:1476 ||| NN
,  ||| S:1476 E:1478 ||| ,
serum  ||| S:1478 E:1484 ||| JJ
sodium ||| S:1484 E:1490 ||| NN
,  ||| S:1490 E:1492 ||| ,
lactate  ||| S:1492 E:1500 ||| JJ
clearance  ||| S:1500 E:1510 ||| NN
rate ||| S:1510 E:1514 ||| NN
,  ||| S:1514 E:1516 ||| ,
PCIS ||| S:1516 E:1520 ||| NNP
,  ||| S:1520 E:1522 ||| ,
fluid  ||| S:1522 E:1528 ||| JJ
infusion  ||| S:1528 E:1537 ||| NN
volume ||| S:1537 E:1543 ||| NN
,  ||| S:1543 E:1545 ||| ,
vasoactive  ||| S:1545 E:1556 ||| NNS
-  ||| S:1556 E:1558 ||| :
inotropic  ||| S:1558 E:1568 ||| JJ
score ||| S:1568 E:1573 ||| NN
,  ||| S:1573 E:1575 ||| ,
mechanical  ||| S:1575 E:1586 ||| JJ
ventilation  ||| S:1586 E:1598 ||| NN
time  ||| S:1598 E:1603 ||| NN
,  ||| S:1603 E:1605 ||| ,
as  ||| S:1605 E:1608 ||| RB
well  ||| S:1608 E:1613 ||| RB
as  ||| S:1613 E:1616 ||| IN
incidence  ||| S:1616 E:1626 ||| NN
of  ||| S:1626 E:1629 ||| IN
multiple  ||| S:1629 E:1638 ||| JJ
organ  ||| S:1638 E:1644 ||| NN
dysfunction  ||| S:1644 E:1656 ||| NN
syndrome  ||| S:1656 E:1665 ||| NN
( ||| S:1665 E:1666 ||| -LRB-
MODS ||| S:1666 E:1670 ||| NNP
) ||| S:1670 E:1671 ||| -RRB-
,  ||| S:1671 E:1673 ||| ,
and  ||| S:1673 E:1677 ||| CC
28  ||| S:1677 E:1680 ||| CD
days  ||| S:1680 E:1685 ||| NNS
in  ||| S:1685 E:1688 ||| IN
-  ||| S:1688 E:1690 ||| :
hospital  ||| S:1690 E:1699 ||| NN
mortality  ||| S:1699 E:1709 ||| NN
were  ||| S:1709 E:1714 ||| VBD
recorded  ||| S:1714 E:1723 ||| VBN
for  ||| S:1723 E:1727 ||| IN
all  ||| S:1727 E:1731 ||| DT
patients.  ||| S:1731 E:1741 ||| NNP
( ||| S:1741 E:1742 ||| -LRB-
1 ||| S:1742 E:1743 ||| LS
)  ||| S:1743 E:1745 ||| -RRB-
HR ||| S:1745 E:1747 ||| NNP
,  ||| S:1747 E:1749 ||| ,
MAP  ||| S:1749 E:1753 ||| NNP
in  ||| S:1753 E:1756 ||| IN
both  ||| S:1756 E:1761 ||| DT
groups  ||| S:1761 E:1768 ||| NNS
were  ||| S:1768 E:1773 ||| VBD
significantly  ||| S:1773 E:1787 ||| RB
higher  ||| S:1787 E:1794 ||| JJR
after  ||| S:1794 E:1800 ||| IN
infusion  ||| S:1800 E:1809 ||| NN
than  ||| S:1809 E:1814 ||| IN
those  ||| S:1814 E:1820 ||| DT
on  ||| S:1820 E:1823 ||| IN
admission ||| S:1823 E:1832 ||| NN
.  ||| S:1832 E:1834 ||| .
There  ||| S:1834 E:1840 ||| EX
were  ||| S:1840 E:1845 ||| VBD
no  ||| S:1845 E:1848 ||| DT
significant  ||| S:1848 E:1860 ||| JJ
difference  ||| S:1860 E:1871 ||| NN
in  ||| S:1871 E:1874 ||| IN
HR  ||| S:1874 E:1877 ||| NNP
and  ||| S:1877 E:1881 ||| CC
MAP  ||| S:1881 E:1885 ||| NNP
at  ||| S:1885 E:1888 ||| IN
1h ||| S:1888 E:1890 ||| NNP
,  ||| S:1890 E:1892 ||| ,
3h ||| S:1892 E:1894 ||| NNP
,  ||| S:1894 E:1896 ||| ,
6h  ||| S:1896 E:1899 ||| NNP
and  ||| S:1899 E:1903 ||| CC
24h  ||| S:1903 E:1907 ||| CD
after  ||| S:1907 E:1913 ||| IN
infusion  ||| S:1913 E:1922 ||| NN
between  ||| S:1922 E:1930 ||| IN
NS  ||| S:1930 E:1933 ||| NNP
group  ||| S:1933 E:1939 ||| NN
and  ||| S:1939 E:1943 ||| CC
HS  ||| S:1943 E:1946 ||| NNP
group.  ||| S:1946 E:1953 ||| NNP
( ||| S:1953 E:1954 ||| -LRB-
2 ||| S:1954 E:1955 ||| LS
)  ||| S:1955 E:1957 ||| -RRB-
OI  ||| S:1957 E:1960 ||| NNP
in  ||| S:1960 E:1963 ||| IN
HS  ||| S:1963 E:1966 ||| NNP
group  ||| S:1966 E:1972 ||| NN
was  ||| S:1972 E:1976 ||| VBD
significantly  ||| S:1976 E:1990 ||| RB
higher  ||| S:1990 E:1997 ||| JJR
than  ||| S:1997 E:2002 ||| IN
that  ||| S:2002 E:2007 ||| DT
on  ||| S:2007 E:2010 ||| IN
admission  ||| S:2010 E:2020 ||| NN
at  ||| S:2020 E:2023 ||| IN
3  ||| S:2023 E:2025 ||| CD
hours  ||| S:2025 E:2031 ||| NNS
after  ||| S:2031 E:2037 ||| IN
infusion  ||| S:2037 E:2046 ||| NN
[ ||| S:2046 E:2047 ||| -LRB-
( ||| S:2047 E:2048 ||| -LRB-
321.  ||| S:2048 E:2053 ||| CD
8  ||| S:2053 E:2055 ||| CD
±  ||| S:2055 E:2057 ||| CD
50.  ||| S:2057 E:2061 ||| CD
7 ||| S:2061 E:2062 ||| CD
)  ||| S:2062 E:2064 ||| -RRB-
vs.  ||| S:2064 E:2068 ||| FW
( ||| S:2068 E:2069 ||| -LRB-
296.  ||| S:2069 E:2074 ||| CD
5  ||| S:2074 E:2076 ||| CD
±  ||| S:2076 E:2078 ||| CD
58.  ||| S:2078 E:2082 ||| CD
2 ||| S:2082 E:2083 ||| CD
)  ||| S:2083 E:2085 ||| -RRB-
mmHg ||| S:2085 E:2089 ||| NNP
,  ||| S:2089 E:2091 ||| ,
t  ||| S:2091 E:2093 ||| VBG
=  ||| S:2093 E:2095 ||| SYM
-2.  ||| S:2095 E:2099 ||| CD
50 ||| S:2099 E:2101 ||| CD
,  ||| S:2101 E:2103 ||| ,
P  ||| S:2103 E:2105 ||| NN
=  ||| S:2105 E:2107 ||| SYM
0.  ||| S:2107 E:2110 ||| CD
018  ||| S:2110 E:2114 ||| CD
] ||| S:2114 E:2115 ||| CD
) ||| S:2115 E:2116 ||| -RRB-
,  ||| S:2116 E:2118 ||| ,
and  ||| S:2118 E:2122 ||| CC
it  ||| S:2122 E:2125 ||| PRP
was  ||| S:2125 E:2129 ||| VBD
significantly  ||| S:2129 E:2143 ||| RB
higher  ||| S:2143 E:2150 ||| JJR
at  ||| S:2150 E:2153 ||| IN
24  ||| S:2153 E:2156 ||| CD
hours  ||| S:2156 E:2162 ||| NNS
after  ||| S:2162 E:2168 ||| IN
infusion  ||| S:2168 E:2177 ||| NN
in  ||| S:2177 E:2180 ||| IN
NS  ||| S:2180 E:2183 ||| NNP
group  ||| S:2183 E:2189 ||| NN
( ||| S:2189 E:2190 ||| -LRB-
325.  ||| S:2190 E:2195 ||| CD
7  ||| S:2195 E:2197 ||| CD
±  ||| S:2197 E:2199 ||| CD
62.  ||| S:2199 E:2203 ||| CD
6 ||| S:2203 E:2204 ||| CD
)  ||| S:2204 E:2206 ||| -RRB-
vs.  ||| S:2206 E:2210 ||| FW
( ||| S:2210 E:2211 ||| -LRB-
304.  ||| S:2211 E:2216 ||| CD
2  ||| S:2216 E:2218 ||| CD
±  ||| S:2218 E:2220 ||| CD
70.  ||| S:2220 E:2224 ||| CD
4 ||| S:2224 E:2225 ||| CD
)  ||| S:2225 E:2227 ||| -RRB-
mmHg ||| S:2227 E:2231 ||| NNP
,  ||| S:2231 E:2233 ||| ,
t  ||| S:2233 E:2235 ||| VBG
=  ||| S:2235 E:2237 ||| SYM
-2.60 ||| S:2237 E:2242 ||| CD
,  ||| S:2242 E:2244 ||| ,
P=0.016 ||| S:2244 E:2251 ||| CD
] ||| S:2251 E:2252 ||| -RRB-
.  ||| S:2252 E:2254 ||| .
There  ||| S:2254 E:2260 ||| EX
were  ||| S:2260 E:2265 ||| VBD
no  ||| S:2265 E:2268 ||| DT
significant  ||| S:2268 E:2280 ||| JJ
differences  ||| S:2280 E:2292 ||| NNS
in  ||| S:2292 E:2295 ||| IN
OI  ||| S:2295 E:2298 ||| NNP
at  ||| S:2298 E:2301 ||| IN
1h ||| S:2301 E:2303 ||| NNP
,  ||| S:2303 E:2305 ||| ,
3h ||| S:2305 E:2307 ||| NNP
,  ||| S:2307 E:2309 ||| ,
6h  ||| S:2309 E:2312 ||| NNP
and  ||| S:2312 E:2316 ||| CC
24h  ||| S:2316 E:2320 ||| CD
after  ||| S:2320 E:2326 ||| IN
infusion  ||| S:2326 E:2335 ||| NN
between  ||| S:2335 E:2343 ||| IN
NS  ||| S:2343 E:2346 ||| NNP
group  ||| S:2346 E:2352 ||| NN
and  ||| S:2352 E:2356 ||| CC
HS  ||| S:2356 E:2359 ||| NNP
group.  ||| S:2359 E:2366 ||| NNP
( ||| S:2366 E:2367 ||| -LRB-
3 ||| S:2367 E:2368 ||| LS
)  ||| S:2368 E:2370 ||| -RRB-
At  ||| S:2370 E:2373 ||| IN
1  ||| S:2373 E:2375 ||| CD
hour  ||| S:2375 E:2380 ||| NN
after  ||| S:2380 E:2386 ||| IN
infusion ||| S:2386 E:2394 ||| NN
,  ||| S:2394 E:2396 ||| ,
serum  ||| S:2396 E:2402 ||| JJ
sodium  ||| S:2402 E:2409 ||| NN
in  ||| S:2409 E:2412 ||| IN
HS  ||| S:2412 E:2415 ||| NNP
group  ||| S:2415 E:2421 ||| NN
was  ||| S:2421 E:2425 ||| VBD
significantly  ||| S:2425 E:2439 ||| RB
higherthan  ||| S:2439 E:2450 ||| VBN
that  ||| S:2450 E:2455 ||| IN
in  ||| S:2455 E:2458 ||| IN
NS  ||| S:2458 E:2461 ||| NNP
group  ||| S:2461 E:2467 ||| NN
[ ||| S:2467 E:2468 ||| -LRB-
( ||| S:2468 E:2469 ||| -LRB-
138.3  ||| S:2469 E:2475 ||| CD
±  ||| S:2475 E:2477 ||| CD
3.8 ||| S:2477 E:2480 ||| CD
) ||| S:2480 E:2481 ||| -RRB-
vs.  ||| S:2481 E:2485 ||| FW
( ||| S:2485 E:2486 ||| -LRB-
135.0  ||| S:2486 E:2492 ||| CD
±  ||| S:2492 E:2494 ||| CD
3.5 ||| S:2494 E:2497 ||| CD
)  ||| S:2497 E:2499 ||| -RRB-
mmol ||| S:2499 E:2503 ||| FW
/ ||| S:2503 E:2504 ||| FW
L ||| S:2504 E:2505 ||| NNP
,  ||| S:2505 E:2507 ||| ,
t=8.77 ||| S:2507 E:2513 ||| NNP
,  ||| S:2513 E:2515 ||| ,
P=0.005 ||| S:2515 E:2522 ||| CD
] ||| S:2522 E:2523 ||| -RRB-
,  ||| S:2523 E:2525 ||| ,
and  ||| S:2525 E:2529 ||| CC
then  ||| S:2529 E:2534 ||| RB
no  ||| S:2534 E:2537 ||| DT
significant  ||| S:2537 E:2549 ||| JJ
difference  ||| S:2549 E:2560 ||| NN
at  ||| S:2560 E:2563 ||| IN
3h ||| S:2563 E:2565 ||| NNP
,  ||| S:2565 E:2567 ||| ,
6h  ||| S:2567 E:2570 ||| NNP
and  ||| S:2570 E:2574 ||| CC
24h  ||| S:2574 E:2578 ||| CD
after  ||| S:2578 E:2584 ||| IN
infusion  ||| S:2584 E:2593 ||| NN
between  ||| S:2593 E:2601 ||| IN
two  ||| S:2601 E:2605 ||| CD
groups.  ||| S:2605 E:2613 ||| CD
( ||| S:2613 E:2614 ||| -LRB-
4 ||| S:2614 E:2615 ||| LS
)  ||| S:2615 E:2617 ||| -RRB-
At  ||| S:2617 E:2620 ||| IN
6  ||| S:2620 E:2622 ||| CD
hours  ||| S:2622 E:2628 ||| NNS
and  ||| S:2628 E:2632 ||| CC
24  ||| S:2632 E:2635 ||| CD
hours  ||| S:2635 E:2641 ||| NNS
after  ||| S:2641 E:2647 ||| IN
treatment ||| S:2647 E:2656 ||| NN
,  ||| S:2656 E:2658 ||| ,
fluid  ||| S:2658 E:2664 ||| JJ
infusion  ||| S:2664 E:2673 ||| NN
volume  ||| S:2673 E:2680 ||| NN
in  ||| S:2680 E:2683 ||| IN
HS  ||| S:2683 E:2686 ||| NNP
group  ||| S:2686 E:2692 ||| NN
was  ||| S:2692 E:2696 ||| VBD
markedly  ||| S:2696 E:2705 ||| RB
less  ||| S:2705 E:2710 ||| JJR
than  ||| S:2710 E:2715 ||| IN
that  ||| S:2715 E:2720 ||| DT
in  ||| S:2720 E:2723 ||| IN
NS  ||| S:2723 E:2726 ||| NNP
group  ||| S:2726 E:2732 ||| NN
[ ||| S:2732 E:2733 ||| -LRB-
6  ||| S:2733 E:2735 ||| CD
h ||| S:2735 E:2736 ||| NNS
:  ||| S:2736 E:2738 ||| :
( ||| S:2738 E:2739 ||| -LRB-
39.  ||| S:2739 E:2743 ||| CD
2  ||| S:2743 E:2745 ||| CD
13.  ||| S:2745 E:2749 ||| CD
9 ||| S:2749 E:2750 ||| CD
)  ||| S:2750 E:2752 ||| -RRB-
vs.  ||| S:2752 E:2756 ||| FW
( ||| S:2756 E:2757 ||| -LRB-
60.  ||| S:2757 E:2761 ||| CD
8  ||| S:2761 E:2763 ||| CD
±  ||| S:2763 E:2765 ||| CD
22.  ||| S:2765 E:2769 ||| CD
4 ||| S:2769 E:2770 ||| CD
)  ||| S:2770 E:2772 ||| -RRB-
ml ||| S:2772 E:2774 ||| FW
/ ||| S:2774 E:2775 ||| FW
kg ||| S:2775 E:2777 ||| FW
,  ||| S:2777 E:2779 ||| ,
t  ||| S:2779 E:2781 ||| VBG
=  ||| S:2781 E:2783 ||| SYM
14.  ||| S:2783 E:2787 ||| CD
21 ||| S:2787 E:2789 ||| CD
,  ||| S:2789 E:2791 ||| ,
P  ||| S:2791 E:2793 ||| NN
=0.  ||| S:2793 E:2797 ||| CD
000 ||| S:2797 E:2800 ||| CD
;  ||| S:2800 E:2802 ||| :
24  ||| S:2802 E:2805 ||| CD
h ||| S:2805 E:2806 ||| NNS
:  ||| S:2806 E:2808 ||| :
( ||| S:2808 E:2809 ||| -LRB-
102.  ||| S:2809 E:2814 ||| CD
9  ||| S:2814 E:2816 ||| CD
±  ||| S:2816 E:2818 ||| CD
27.  ||| S:2818 E:2822 ||| CD
7 ||| S:2822 E:2823 ||| CD
)  ||| S:2823 E:2825 ||| -RRB-
vs.  ||| S:2825 E:2829 ||| FW
( ||| S:2829 E:2830 ||| -LRB-
130.  ||| S:2830 E:2835 ||| CD
6  ||| S:2835 E:2837 ||| CD
±  ||| S:2837 E:2839 ||| CD
33.  ||| S:2839 E:2843 ||| CD
2  ||| S:2843 E:2845 ||| CD
)  ||| S:2845 E:2847 ||| -RRB-
ml ||| S:2847 E:2849 ||| FW
/ ||| S:2849 E:2850 ||| FW
kg ||| S:2850 E:2852 ||| FW
,  ||| S:2852 E:2854 ||| ,
t=  ||| S:2854 E:2857 ||| CD
8.  ||| S:2857 E:2860 ||| CD
85 ||| S:2860 E:2862 ||| CD
,  ||| S:2862 E:2864 ||| ,
P  ||| S:2864 E:2866 ||| NN
=  ||| S:2866 E:2868 ||| SYM
0.  ||| S:2868 E:2871 ||| CD
005 ||| S:2871 E:2874 ||| CD
] ||| S:2874 E:2875 ||| -RRB-
.  ||| S:2875 E:2877 ||| .
Urine  ||| S:2877 E:2883 ||| JJ
output  ||| S:2883 E:2890 ||| NN
had  ||| S:2890 E:2894 ||| VBD
not  ||| S:2894 E:2898 ||| RB
significant  ||| S:2898 E:2910 ||| JJ
different  ||| S:2910 E:2920 ||| JJ
between  ||| S:2920 E:2928 ||| IN
the  ||| S:2928 E:2932 ||| DT
two  ||| S:2932 E:2936 ||| CD
groups.  ||| S:2936 E:2944 ||| CD
( ||| S:2944 E:2945 ||| -LRB-
5 ||| S:2945 E:2946 ||| LS
)  ||| S:2946 E:2948 ||| -RRB-
There  ||| S:2948 E:2954 ||| EX
were  ||| S:2954 E:2959 ||| VBD
no  ||| S:2959 E:2962 ||| DT
significant  ||| S:2962 E:2974 ||| JJ
differences  ||| S:2974 E:2986 ||| NNS
in  ||| S:2986 E:2989 ||| IN
24h  ||| S:2989 E:2993 ||| NNP
PCIS ||| S:2993 E:2997 ||| NNP
,  ||| S:2997 E:2999 ||| ,
24h  ||| S:2999 E:3003 ||| CD
lactate  ||| S:3003 E:3011 ||| JJ
clearance  ||| S:3011 E:3021 ||| NN
rate ||| S:3021 E:3025 ||| NN
,  ||| S:3025 E:3027 ||| ,
vasoactive  ||| S:3027 E:3038 ||| NNS
-  ||| S:3038 E:3040 ||| :
inotropic  ||| S:3040 E:3050 ||| JJ
score  ||| S:3050 E:3056 ||| NN
and  ||| S:3056 E:3060 ||| CC
mechanical  ||| S:3060 E:3071 ||| JJ
ventilation  ||| S:3071 E:3083 ||| NN
time  ||| S:3083 E:3088 ||| NN
between  ||| S:3088 E:3096 ||| IN
the  ||| S:3096 E:3100 ||| DT
two  ||| S:3100 E:3104 ||| CD
groups ||| S:3104 E:3110 ||| NNS
.  ||| S:3110 E:3112 ||| .
The  ||| S:3112 E:3116 ||| DT
incidence  ||| S:3116 E:3126 ||| NN
of  ||| S:3126 E:3129 ||| IN
MODS  ||| S:3129 E:3134 ||| NNP
( ||| S:3134 E:3135 ||| -LRB-
80.  ||| S:3135 E:3139 ||| CD
0 ||| S:3139 E:3140 ||| CD
%  ||| S:3140 E:3142 ||| NN
in  ||| S:3142 E:3145 ||| IN
HS  ||| S:3145 E:3148 ||| NNP
group ||| S:3148 E:3153 ||| NN
,  ||| S:3153 E:3155 ||| ,
70.  ||| S:3155 E:3159 ||| CD
0 ||| S:3159 E:3160 ||| CD
%  ||| S:3160 E:3162 ||| NN
in  ||| S:3162 E:3165 ||| IN
NS  ||| S:3165 E:3168 ||| NNP
group ||| S:3168 E:3173 ||| NN
)  ||| S:3173 E:3175 ||| -RRB-
and  ||| S:3175 E:3179 ||| CC
mortality  ||| S:3179 E:3189 ||| NN
rate ||| S:3189 E:3193 ||| NN
( ||| S:3193 E:3194 ||| -LRB-
5.  ||| S:3194 E:3197 ||| CD
0 ||| S:3197 E:3198 ||| CD
%  ||| S:3198 E:3200 ||| NN
in  ||| S:3200 E:3203 ||| IN
HS  ||| S:3203 E:3206 ||| NNP
group ||| S:3206 E:3211 ||| NN
,  ||| S:3211 E:3213 ||| ,
8.  ||| S:3213 E:3216 ||| CD
3 ||| S:3216 E:3217 ||| CD
%  ||| S:3217 E:3219 ||| NN
in  ||| S:3219 E:3222 ||| IN
NS  ||| S:3222 E:3225 ||| NNP
group ||| S:3225 E:3230 ||| NN
)  ||| S:3230 E:3232 ||| -RRB-
were  ||| S:3232 E:3237 ||| VBD
similar  ||| S:3237 E:3245 ||| JJ
in  ||| S:3245 E:3248 ||| IN
both  ||| S:3248 E:3253 ||| DT
groups ||| S:3253 E:3259 ||| NNS
.  ||| S:3259 E:3261 ||| .
The  ||| S:3261 E:3265 ||| DT
3 ||| S:3265 E:3266 ||| CD
%  ||| S:3266 E:3268 ||| NN
hypertonic  ||| S:3268 E:3279 ||| NN
saline  ||| S:3279 E:3286 ||| NNS
was  ||| S:3286 E:3290 ||| VBD
effective  ||| S:3290 E:3300 ||| JJ
as  ||| S:3300 E:3303 ||| IN
resuscitation  ||| S:3303 E:3317 ||| JJ
fluid  ||| S:3317 E:3323 ||| NN
in  ||| S:3323 E:3326 ||| IN
pediatric  ||| S:3326 E:3336 ||| JJ
septic  ||| S:3336 E:3343 ||| JJ
shock  ||| S:3343 E:3349 ||| NN
with  ||| S:3349 E:3354 ||| IN
respect  ||| S:3354 E:3362 ||| NN
to  ||| S:3362 E:3365 ||| TO
restoration  ||| S:3365 E:3377 ||| NN
of  ||| S:3377 E:3380 ||| IN
hemodynamic  ||| S:3380 E:3392 ||| JJ
stability  ||| S:3392 E:3402 ||| NN
without  ||| S:3402 E:3410 ||| IN
obvious  ||| S:3410 E:3418 ||| JJ
side  ||| S:3418 E:3423 ||| NN
effects ||| S:3423 E:3430 ||| NNS
.  ||| S:3430 E:3432 ||| .
Hypertonic  ||| S:3432 E:3443 ||| JJ
saline  ||| S:3443 E:3450 ||| NN
could  ||| S:3450 E:3456 ||| MD
more  ||| S:3456 E:3461 ||| RBR
rapidly  ||| S:3461 E:3469 ||| RB
improve  ||| S:3469 E:3477 ||| VB
oxygenation  ||| S:3477 E:3489 ||| NNS
and  ||| S:3489 E:3493 ||| CC
need  ||| S:3493 E:3498 ||| VBP
less  ||| S:3498 E:3503 ||| RBR
fluid  ||| S:3503 E:3509 ||| JJ
infusion  ||| S:3509 E:3518 ||| NN
volume  ||| S:3518 E:3525 ||| NN
compared  ||| S:3525 E:3534 ||| VBN
with  ||| S:3534 E:3539 ||| IN
normal  ||| S:3539 E:3546 ||| JJ
saline ||| S:3546 E:3552 ||| NN
.  ||| S:3552 E:3554 ||| .
